Weber JS - Search Results

1

CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.

Thompson B, Strange A, Amato CM, Hester-McCullough J, Sarnaik AA, Weber JS, Woods DM. Thompson B, et al. Among authors: weber js. J Immunol. 2023 Sep 1;211(5):735-742. doi: 10.4049/jimmunol.2300250. J Immunol. 2023. PMID: 37466381

2

WEE1 epigenetically modulates 5-hmC levels by pY37-H2B dependent regulation of IDH2 gene expression.

Mahajan NP, Malla P, Bhagwat S, Sharma V, Sarnaik A, Kim J, Pilon-Thomas S, Weber J, Mahajan K. Mahajan NP, et al. Oncotarget. 2017 Nov 10;8(63):106352-106368. doi: 10.18632/oncotarget.22374. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29290954 Free PMC article.

3

Dichotomous Nitric Oxide-Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in Melanoma.

Garg SK, Sun J, Kim Y, Whiting J, Sarnaik A, Conejo-Garcia JR, Phelps M, Weber JS, Mulé JJ, Markowitz J. Garg SK, et al. Among authors: weber js. Cancers (Basel). 2023 Mar 14;15(6):1755. doi: 10.3390/cancers15061755. Cancers (Basel). 2023. PMID: 36980641 Free PMC article.

4

Melanoma-Modern Treatment for Metastatic Melanoma.

Dimitrova M, Weber J. Dimitrova M, et al. Cancer J. 2024 Mar-Apr 01;30(2):79-83. doi: 10.1097/PPO.0000000000000707. Cancer J. 2024. PMID: 38527260 Review.

5

State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers.

Strum S, Andersen MH, Svane IM, Siu LL, Weber JS. Strum S, et al. Among authors: weber js. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e438592. doi: 10.1200/EDBK_438592. Am Soc Clin Oncol Educ Book. 2024. PMID: 38669611 Free article. Review.

6

Recent advances in adjuvant therapy for patients with melanoma.

Weber J. Weber J. ESMO Open. 2018 Mar 23;3(3):e000337. doi: 10.1136/esmoopen-2018-000337. eCollection 2018. ESMO Open. 2018. PMID: 29636990 Free PMC article. No abstract available.

7

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.

Weber JS, Carlino MS, Khattak A, Meniawy T, Ansstas G, Taylor MH, Kim KB, McKean M, Long GV, Sullivan RJ, Faries M, Tran TT, Cowey CL, Pecora A, Shaheen M, Segar J, Medina T, Atkinson V, Gibney GT, Luke JJ, Thomas S, Buchbinder EI, Healy JA, Huang M, Morrissey M, Feldman I, Sehgal V, Robert-Tissot C, Hou P, Zhu L, Brown M, Aanur P, Meehan RS, Zaks T. Weber JS, et al. Lancet. 2024 Feb 17;403(10427):632-644. doi: 10.1016/S0140-6736(23)02268-7. Epub 2024 Jan 18. Lancet. 2024. PMID: 38246194 Clinical Trial.

8

Immunotherapy in the adjuvant setting for high-risk melanoma.

Weber JS. Weber JS. Clin Adv Hematol Oncol. 2018 Aug;16(8):546-548. Clin Adv Hematol Oncol. 2018. PMID: 30148825 Review. No abstract available.

9

A genome-wide association study of germline variation and melanoma prognosis.

Chat V, Dagayev S, Moran U, Snuderl M, Weber J, Ferguson R, Osman I, Kirchhoff T. Chat V, et al. Front Oncol. 2023 Jan 19;12:1050741. doi: 10.3389/fonc.2022.1050741. eCollection 2022. Front Oncol. 2023. PMID: 36741706 Free PMC article.

10

Are vaccines making a comeback in melanoma?

Weber JS. Weber JS. Clin Adv Hematol Oncol. 2023 Nov;21(11):603-605. Clin Adv Hematol Oncol. 2023. PMID: 37948598 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page